iHear MatriX vs Otofonix Groove

The iHear MatriX is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.8/5, placing it in the top 40% of the OTC hearing aid category in our lab testing. At $499, this behind-the-ear device delivers solid speech performance that exceeds category averages, though with a notable tradeoff in streaming capabilities. Speech clarity is a clear strength for the MatriX. In quiet environments, it scores 4.0/5—a solid result that sits 1.17 points above the OTC category average. Speech in noise performance is more modest at 2.4/5, which is mixed in absolute terms but still 0.96 points above the typical OTC device. Feedback handling is excellent at 5.0/5, meaning users should experience minimal whistling during daily wear. The most significant limitation is music streaming, which scores 0.0/5—well below the category average of 1.92/5. While the MatriX supports both iPhone and Android streaming, audio fidelity for music is poor in our testing. Own-voice comfort is mixed at 2.7/5, roughly in line with category norms. The MatriX shows meaningful improvement with tuning, jumping from an Initial Score of 3.7/5 to a Tuned Score of 4.2/5. This suggests users who invest time in adjustment can unlock better performance. For budget-conscious buyers prioritizing speech understanding over music quality, the MatriX offers competitive value in its price range, though alternatives like the Elehear Beyond score higher overall at similar pricing.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.